Cargando…

Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts

Drug resistance in cancer, especially in leukemia, creates a dilemma in treatment planning. Consequently, studies related to the mechanisms underlying drug resistance, the molecular pathways involved in this phenomenon, and alternate therapies have attracted the attention of researchers. Among a var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fathi, Ezzatollah, Sanaat, Zohreh, Farahzadi, Raheleh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779935/ https://www.ncbi.nlm.nih.gov/pubmed/31730689 http://dx.doi.org/10.5045/br.2019.54.3.165

Ejemplares similares

Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation
por: Fathi, Ezzatollah, et al.
Publicado: (2019)

A general view of CD33(+) leukemic stem cells and CAR-T cells as interesting targets in acute myeloblatsic leukemia therapy
por: Fathi, Ezzatollah, et al.
Publicado: (2020)

Interleukin-6, -8, and TGF-β Secreted from Mesenchymal Stem Cells Show Functional Role in Reduction of Telomerase Activity of Leukemia Cell Via Wnt5a/β-Catenin and P53 Pathways
por: Fathi, Ezzatollah, et al.
Publicado: (2020)

Oxidative stress regulation and related metabolic pathways in epithelial–mesenchymal transition of breast cancer stem cells
por: Farahzadi, Raheleh, et al.
Publicado: (2023)

Investigation of L-carnitine effects on CD44(+) cancer stem cells from MDA-MB-231 breast cancer cell line as anti-cancer therapy
por: Farahzadi, Raheleh, et al.
Publicado: (2023)

Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect
por: Montazersaheb, Soheila, et al.
Publicado: (2022)

Enhancement of osteogenic differentiation of rat adipose tissue-derived mesenchymal stem cells by zinc sulphate under electromagnetic field via the PKA, ERK1/2 and Wnt/β-catenin signaling pathways
por: Fathi, Ezzatollah, et al.
Publicado: (2017)

Targeting the stem cell niche micro-environment as therapeutic strategies in aging
por: Farahzadi, Raheleh, et al.
Publicado: (2023)

Mesenchymal stem cells promote caspase-3 expression of SH-SY5Y neuroblastoma cells via reducing telomerase activity and telomere length
por: Fathi, Ezzatollah, et al.
Publicado: (2021)

Granulocyte differentiation of rat bone marrow resident C-kit(+) hematopoietic stem cells induced by mesenchymal stem cells could be considered as new option in cell-based therapy
por: Farahzadi, Raheleh, et al.
Publicado: (2023)

Mesenchymal stem cells cause induction of granulocyte differentiation of rat bone marrow C-kit(+) hematopoietic stem cells through JAK3/STAT3, ERK, and PI3K signaling pathways
por: Fathi, Ezzatollah, et al.
Publicado: (2022)

L-carnitine Effectively Induces hTERT Gene Expression of Human Adipose Tissue-derived Mesenchymal Stem Cells Obtained from the Aged Subjects
por: Farahzadi, Raheleh, et al.
Publicado: (2016)

Zinc sulfate contributes to promote telomere length extension via increasing telomerase gene expression, telomerase activity and change in the TERT gene promoter CpG island methylation status of human adipose-derived mesenchymal stem cells
por: Farahzadi, Raheleh, et al.
Publicado: (2017)

Silver nanoparticles induce the cardiomyogenic differentiation of bone marrow derived mesenchymal stem cells via telomere length extension
por: Adibkia, Khosro, et al.
Publicado: (2021)

Rat adipose-derived mesenchymal stem cells aging reduction by zinc sulfate under extremely low frequency electromagnetic field exposure is associated with increased telomerase reverse transcriptase gene expression
por: Fathi, Ezzatollah, et al.
Publicado: (2017)

A Mini Overview of Isolation, Characterization and Application of Amniotic Fluid Stem Cells
por: Gholizadeh-Ghalehaziz, Shiva, et al.
Publicado: (2015)

An Overview of Autophagy in Hematopoietic Stem Cell Transplantation
por: Montazersaheb, Soheila, et al.
Publicado: (2022)

Mesenchymal Stem Cells cause Telomere Length Reduction of Molt-4 Cells via Caspase-3, BAD and P53 Apoptotic Pathway
por: Heidari, Hamid Reza, et al.
Publicado: (2021)

Acute Myeloid Leukemia: Focus on Novel Therapeutic Strategies
por: Lin, Tara L., et al.
Publicado: (2012)

Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia
por: Raeisi, Mortaza, et al.
Publicado: (2019)

Does Chemotherapy Change Expression of VEGF A&C and MVD in Acute Myeloid Leukemia?
por: Sanaat, Zohreh, et al.
Publicado: (2014)

Human acute myeloid leukemia stem cells: evolution of concept
por: Shin, Dong-Yeop
Publicado: (2022)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Gene Expression of VEGF-A and VEGF-C in Peripheral Blood Mononuclear Cells of Iranian Patients with Acute Myeloid Leukemia
por: Aliparasti, Mohammad Reza, et al.
Publicado: (2013)

Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications
por: Fracchiolla, Nicola Stefano, et al.
Publicado: (2017)

Mummy Material Can Promote Differentiation of Adipose Derived Stem Cells into Osteoblast through Enhancement of Bone Specific Transcription Factors Expression
por: Eyvazi, Maryam, et al.
Publicado: (2018)

Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells
por: Tan, Zhenya, et al.
Publicado: (2022)

Molecular mechanisms for stemness maintenance of acute myeloid leukemia stem cells
por: Wang, Jiazhen, et al.
Publicado: (2019)

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)
por: Henkes, Martin, et al.
Publicado: (2008)

Liver Involvement with Acute Myeloid Leukemia
por: Mathews, Emily, et al.
Publicado: (2008)

Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
por: Niu, Jialan, et al.
Publicado: (2022)

Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment
por: Gbolahan, Olumide Babajide, et al.
Publicado: (2017)

A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges
por: Awada, Hassan, et al.
Publicado: (2022)

Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities
por: Stahl, Maximilian, et al.
Publicado: (2016)

Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
por: Zhao, Haijun, et al.
Publicado: (2022)

Chronic myeloid leukemia stem cells: targeting therapeutic implications
por: Mojtahedi, Hanieh, et al.
Publicado: (2021)

Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy
por: Bocchia, Monica, et al.
Publicado: (2022)

A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy
por: Sun, Luchen, et al.
Publicado: (2023)

Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms
por: Brenner, Annette K., et al.
Publicado: (2017)

Novel therapeutic options in Acute Myeloid Leukemia
por: Medinger, Michael, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7j8jgf4ksodamr020vvgpdjni2